Literature DB >> 17095104

Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze.

Dominique Drapier1, Danièle Bentué-Ferrer, Bruno Laviolle, Bruno Millet, Hervé Allain, Michel Bourin, Jean-Michel Reymann.   

Abstract

Antidepressants are usually prescribed for the treatment of depression but more recently have also been recommended for the treatment of anxiety disorders. The purpose of this study was to investigate the anxiogenic- or anxiolytic-like effects of an acute administration of antidepressants (serotonergic and noradrenergic compounds) in male Wistar rats submitted to the elevated plus-maze. Fluoxetine (2.5, 5, 10, 15mg/kg), paroxetine (0.1, 0.5, 3, 12mg/kg) and desipramine (2.5, 5, 10mg/kg) or their vehicles were administered intraperitoneally 30min prior to testing. Diazepam (0.5, 1.5, 2.5mg/kg) was used as a positive comparator for anxiolytic effect. In comparison with control animals, the percentage of time the rats treated with fluoxetine (5 and 10mg/kg) and paroxetine (3 and 12mg/kg) spent in the open arms decreased. The percent of inactive time spent in the open arms also decreased in rats given fluoxetine (5 and 10mg/kg) and paroxetine (12mg/kg). Desipramine was inactive on all these parameters. In conclusion, acute treatment with fluoxetine and paroxetine, but not with desipramine, produced a pattern of anxiety behavior. Thus, the pharmacological mechanism appears to be due more to serotonergic than adrenergic neurotransmission. The elevated plus-maze exhibits good sensitivity for detecting anxiogenic effects of antidepressant drugs and the conventional parameters are sufficient and reliable for detecting such effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095104     DOI: 10.1016/j.bbr.2006.10.002

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  27 in total

1.  Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents.

Authors:  Amanda A Braun; Matthew R Skelton; Charles V Vorhees; Michael T Williams
Journal:  Pharmacol Biochem Behav       Date:  2010-09-24       Impact factor: 3.533

2.  Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.

Authors:  Sergio D Iñiguez; Brandon L Warren; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

Review 3.  Kappa-opioid ligands in the study and treatment of mood disorders.

Authors:  William A Carlezon; Cécile Béguin; Allison T Knoll; Bruce M Cohen
Journal:  Pharmacol Ther       Date:  2009-06-02       Impact factor: 12.310

4.  Androgenic influence on serotonergic activation of the HPA stress axis.

Authors:  Nirupa Goel; Kimberly S Plyler; Derek Daniels; Tracy L Bale
Journal:  Endocrinology       Date:  2011-03-08       Impact factor: 4.736

5.  Zebrafish Behavior in Novel Environments: Effects of Acute Exposure to Anxiolytic Compounds and Choice of Danio rerio Line.

Authors:  James Sackerman; Jennifer J Donegan; Colin S Cunningham; Ngoc Nhung Nguyen; Kelly Lawless; Adam Long; Robert H Benno; Georgianna G Gould
Journal:  Int J Comp Psychol       Date:  2010-01-01

6.  Chronic exposure to fluoxetine of female mice before mating causes impaired stress resilience in female offspring.

Authors:  Chenghao Yang; Jijian Si; Lin Suo; Yan Zhang; Jie Li
Journal:  J Neural Transm (Vienna)       Date:  2019-09-04       Impact factor: 3.575

7.  Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.

Authors:  Leslie R Amodeo; Venuz Y Greenfield; Danielle E Humphrey; Veronica Varela; Joseph A Pipkin; Shannon E Eaton; Jelesa D Johnson; Christopher P Plant; Zachary R Harmony; Li Wang; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2015-07-05       Impact factor: 4.530

Review 8.  Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.

Authors:  William A Carlezon; Andrew D Krystal
Journal:  Depress Anxiety       Date:  2016-10       Impact factor: 6.505

9.  Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Authors:  Cedric Mombereau; Tamar L Gur; Jennifer Onksen; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2009-12-14       Impact factor: 5.176

10.  Role of the amygdala in antidepressant effects on hippocampal cell proliferation and survival and on depression-like behavior in the rat.

Authors:  Jorge E Castro; Emilio Varea; Cristina Márquez; Maria Isabel Cordero; Guillaume Poirier; Carmen Sandi
Journal:  PLoS One       Date:  2010-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.